Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1750
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD ; day:28 ; month:2 ; year:2019 ; pages:1-9
Lung ; (28.2.2019), 1-9
- Creator
-
Böcskei, Renáta M.
Benczúr, Béla
Losonczy, György
Illyés, Miklós
Cziráki, Attila
Müller, Veronika
Bohács, Anikó
Bikov, András
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00408-019-00211-w
- URN
-
urn:nbn:de:101:1-2019032602492320548399
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Böcskei, Renáta M.
- Benczúr, Béla
- Losonczy, György
- Illyés, Miklós
- Cziráki, Attila
- Müller, Veronika
- Bohács, Anikó
- Bikov, András
- SpringerLink (Online service)
Other Objects (12)
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients
Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients
Urokinase-type plasminogen activator receptor in vascular calcification
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Soluble urokinase plasminogen activator receptor (suPAR) and glomerular disease in children: a narrative review
Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients
Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients
Urokinase-type plasminogen activator receptor in vascular calcification
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Soluble urokinase plasminogen activator receptor (suPAR) and glomerular disease in children: a narrative review
Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients
Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients
Urokinase-type plasminogen activator receptor in vascular calcification
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Soluble urokinase plasminogen activator receptor (suPAR) and glomerular disease in children: a narrative review
Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden